by Emmitt Barry, with reporting from Worthy News Jerusalem Bureau Staff
(Worthy News) – Israeli biotech company Matricelf is pioneering a breakthrough that could transform paralysis treatment worldwide — repairing spinal cord injuries with tissue engineered from a patient’s own cells.
Each year, around half a million people suffer spinal injuries that often lead to lifelong paralysis. Now, Matricelf’s team says they are closer than ever to reversing that outcome.
“A drug cannot bring back a new liver, brain, or spinal cord,” said Gil, one of the company’s lead scientists. “What we are offering is the potential to cure diseases that drugs cannot.”
Inside the company’s Tel Aviv–area lab, researchers extract fatty tissue and blood from patients to generate stem cells that are turned into personalized neural tissue — used to replace damaged sections of the spinal cord. “The fatty tissue provides the scaffolding that allows the cells to form functional neural networks,” explained Dr. Tamar, a senior researcher.
The project builds on research by Prof. Tal Dvir of Tel Aviv University’s Sagol Center for Regenerative Biotechnology, where paralyzed rats regained mobility within days of treatment. After these results, Israel’s Ministry of Health approved the first “compassionate use” clinical trials for eight Israeli patients.
“It’s part of our national pride to have this tested here first,” said Gil.
The process takes about six months from cell collection to implantation. Once transplanted, the new tissue begins transmitting signals to the host, gradually reestablishing communication between the brain and spinal cord.
The research carries special urgency in Israel, where many soldiers and reservists have suffered spinal injuries during the war against Hamas. Early trials will target patients with clearly defined localized injuries.
“We know exactly where the communication is cut off,” Gil said. “By placing our implant there, we can restore the circuit — literally close the loop.”
If successful, the innovation could redefine rehabilitation medicine and offer new hope to millions. As one researcher summarized, “We’re not just repairing tissue — we’re restoring lives.”
Copyright 1999-2025 Worthy News. This article was originally published on Worthy News and was reproduced with permission.
The following code is how the above article is generated with the Worthy Suite WordPress Plugin.
[worthy_plugins_news_story_body]This is how you display a story with an image.
Israeli Scientists Pioneer Breakthrough Spinal Cord Regeneration Technology
by Emmitt Barry, with reporting from Worthy News Jerusalem Bureau Staff
(Worthy News) – Israeli biotech company Matricelf is pioneering a breakthrough that could transform paralysis treatment worldwide — repairing spinal cord injuries with tissue engineered from a patient’s own cells.
Each year, around half a million people suffer spinal injuries that often lead to lifelong paralysis. Now, Matricelf’s team says they are closer than ever to reversing that outcome.
“A drug cannot bring back a new liver, brain, or spinal cord,” said Gil, one of the company’s lead scientists. “What we are offering is the potential to cure diseases that drugs cannot.”
Inside the company’s Tel Aviv–area lab, researchers extract fatty tissue and blood from patients to generate stem cells that are turned into personalized neural tissue — used to replace damaged sections of the spinal cord. “The fatty tissue provides the scaffolding that allows the cells to form functional neural networks,” explained Dr. Tamar, a senior researcher.
The project builds on research by Prof. Tal Dvir of Tel Aviv University’s Sagol Center for Regenerative Biotechnology, where paralyzed rats regained mobility within days of treatment. After these results, Israel’s Ministry of Health approved the first “compassionate use” clinical trials for eight Israeli patients.
“It’s part of our national pride to have this tested here first,” said Gil.
The process takes about six months from cell collection to implantation. Once transplanted, the new tissue begins transmitting signals to the host, gradually reestablishing communication between the brain and spinal cord.
The research carries special urgency in Israel, where many soldiers and reservists have suffered spinal injuries during the war against Hamas. Early trials will target patients with clearly defined localized injuries.
“We know exactly where the communication is cut off,” Gil said. “By placing our implant there, we can restore the circuit — literally close the loop.”
If successful, the innovation could redefine rehabilitation medicine and offer new hope to millions. As one researcher summarized, “We’re not just repairing tissue — we’re restoring lives.”
Copyright 1999-2025 Worthy News. This article was originally published on Worthy News and was reproduced with permission.
[worthy_plugins_news_story_title]
<div style="text-align:right; padding:0px 0px 10px 15px; float:right; width:300px;"><img src="[worthy_plugins_news_story_image name=sm_medium]" alt="" /></div>[worthy_plugins_news_story_body]